Accrued expenses consisted of the following (in thousands):
June 30,2024
December 31,2023
Accrued pre-clinical and clinical costs
$
1,174
1,449
Accrued product development costs
737
745
Accrued license costs
4,125
4,825
Accrued compensation
2,297
2,326
Accrued administrative costs
625
343
Accrued interest
1,530
1,342
Total
10,488
11,030
No definition available.
Tabular disclosure of the components of accrued liabilities.